A Phase 1 Study to Assess the Safety, Tolerability, and Pharmacokinetics of Multiple Escalating Oral Doses of PF-07081532 in Adults With Type 2 Diabetes Mellitus
A Phase 1 Study to Assess the Safety, Tolerability, and Pharmacokinetics of Multiple Escalating Oral Doses of PF-07081532 in Adults With Type 2 Diabetes Mellitus. A Phase 1, Randomized, Double-Blind,
Sponsor-Open, Placebo-Controlled Study to Assess the Safety, Tolerability, and Pharmacokinetics of
Multiple Escalating Oral Doses of PF-07081532 in Adult Participants With Type 2 Diabetes Mellitus.
Category & Conditions: Diabetes and Metabolic Disorders
Medicine: PF-07081532
ClinicalTrials.gov Identifier (NCT): NCT04305587
Protocol ID: C3991002
PrintDownloadOpen Plain Language Summary Result: Click here